MDIC Quality Summit Unveils New Risk-Based Framework, ‘Safe Space’ Recall Initiative

During a recent summit, the Medical Device Innovation Consortium Case for Quality Collaborative Community introduced a new risk-based CAPA framework that moves away from the current compliance-focused “one-size-fits-all” approach to a more comprehensive strategy. The summit also discussed how the industry can more effectively and quickly notify consumers about recalls.

Making any regulatory matter “cool” may seem impossible, especially in the realm of quality assurance. But not according to Kathryn Merrill, global quality program director at Medtronic. For the last five years, Merrill has led an initiative from the Medical Device Innovation Consortium (MDIC) with the goal of changing the way device industry views corrective and preventative actions (CAPA) — or, making CAPA cool.

Launched in 2018, #makeCAPAcool is an attempt to improve CAPA strategies by recasting the often-arduous process as part of a...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

New EU Rules Limit Chinese Participation In Medtech Procurement

26 Jun 2025

• By Amanda Maxwell

From June 30, new European Commission rules will attempt to redress an imbalance in medtech trade between the EU and the People’s Republic of China.

FDA Regulations ‘Lock Out’ Clinically Proven Neuromodulation Devices

25 Jun 2025

• By Natasha Barrow

Flow Neuroscience's neuromodulation headset for the treatment of depression is approved and marketed in the EU. However, two years on, the company is still waiting for US FDA approval despite being assigned breakthrough device designation.

Guidance Details EU Approach On Medtech, AI Regulation Interplay

25 Jun 2025

• By Amanda Maxwell

Overlapping clinical testing requirements and decision-making around significant changes to MDAI are among the tricky subjects that the new document explains.

UK MHRA Joins New Global Network For Safe Use Of AI In Healthcare

24 Jun 2025

• By Natasha Barrow

The UK's regulatory agency is the first to join a new international network for oversight of AI in healthcare run by a non-profit organization, HealthAI, the global agency for responsible AI in health.

UK Trails NHS 10-Year Plan With Launch Imminent

26 Jun 2025

• By Ashley Yeo

Healthcare product industries await publication of the NHS 10-Year Plan, due out the coming days, which will focus on health generally not just the NHS, UK health secretary Wes Streeting said during a final prelaunch event on 24 June.